These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 3534173)
1. The evaluation and treatment of hypercholesterolemia in primary care practice. Peters WL; Goroll AH J Gen Intern Med; 1986; 1(3):183-95. PubMed ID: 3534173 [No Abstract] [Full Text] [Related]
7. Treatment of hypercholesterolemia in patients with known coronary artery disease. Schlant RC Heart Dis Stroke; 1993; 2(5):373-6. PubMed ID: 8137037 [No Abstract] [Full Text] [Related]
8. [Cholesterol--the main risk factor in ischemic heart disease]. Heyden S; Kroos S Schweiz Rundsch Med Prax; 1988 Nov; 77(48):1312-7. PubMed ID: 3064242 [No Abstract] [Full Text] [Related]
9. Cholesterol lowering in the elderly population. Coordinating Committee of the National Cholesterol Education Program. Grundy SM; Cleeman JI; Rifkind BM; Kuller LH Arch Intern Med; 1999 Aug 9-23; 159(15):1670-8. PubMed ID: 10448768 [TBL] [Abstract][Full Text] [Related]
10. Hypercholesterolemia in children. Shamir R; Lerner A; Fisher EA Isr Med Assoc J; 2000 Oct; 2(10):767-71. PubMed ID: 11344730 [No Abstract] [Full Text] [Related]
11. [Hypercholesterolemia: to treat or not to treat? That is the question]. Ducobu J Rev Med Brux; 1994; 15(3):124-31. PubMed ID: 8066357 [TBL] [Abstract][Full Text] [Related]
13. [The effect of ketoconazole on the cholesterol content of the blood serum lipoproteins and bile in experimental hypercholesterolemia]. Dushkin MI; Ivanova MV Eksp Klin Farmakol; 1992; 55(2):47-9. PubMed ID: 1422455 [TBL] [Abstract][Full Text] [Related]
14. National cholesterol education program (NCEP) guidelines too complex. Feeman WE Prev Cardiol; 2005; 8(3):188. PubMed ID: 16108130 [No Abstract] [Full Text] [Related]
15. Current attempts at prevention of ischaemic heart disease. Sharland DE Gerontol Clin (Basel); 1971; 13(1):82-8. PubMed ID: 5547262 [No Abstract] [Full Text] [Related]
16. Reassessment of the value of lowering serum cholesterol. Questioning the wisdom of widespread intervention. Labreche DG Clin Pharm; 1988 Aug; 7(8):592-603. PubMed ID: 3048850 [No Abstract] [Full Text] [Related]
17. [Lipid therapy. Goal and use in prevention of coronary heart disease]. Windler E; Greten H Internist (Berl); 1996 Dec; 37(12):1244-8. PubMed ID: 9081925 [No Abstract] [Full Text] [Related]
18. Should cholesterol-lowering drugs be used routinely to treat moderate hypercholesterolemia in patients with serum cholesterol levels of 6.20 to 6.85 mmol/L (240 to 265 mg/dL). An opposing view. Zweig S J Fam Pract; 1988 Jun; 26(6):670-5. PubMed ID: 3132527 [No Abstract] [Full Text] [Related]
19. Hypercholesterolemia in elderly persons: resolving the treatment dilemma. Denke MA; Grundy SM Ann Intern Med; 1990 May; 112(10):780-92. PubMed ID: 2184712 [TBL] [Abstract][Full Text] [Related]